Custom-made Drugs & Platforms

VSR’s methodology is based on translational research and leverages a recursive process continuously analysing the Structure–Activity Relationship (SAR) of natural scaffolds and semi-synthetic new molecular entities to recursively improve their efficacy, selectivity and bioavailability. Notably, new molecular entities developed through this approach usually enjoy a higher patentability. Execution of such methodology is possible thanks to VSR’s multidisciplinary laboratory team (pharmacology, biology, genetics, medicinal chemistry) and established partnerships with leading scientific institutions (e.g. CNR).